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Abstract
Excessive loss of pancreatic β-cells, mainly through apoptosis, contributes to the development of diabetic
hyperglycemia. Oxidative stress plays a major role in the process of β-cell apoptosis due to low expression level of
endogenous antioxidants in the β-cells. Peroxiredoxins (PRDX) are a family of peroxide reductases which uses
thioredoxin to clear peroxides. Several members of PRDX have been found in β-cells and recent studies suggested
that these antioxidant enzymes possess protective effects in β-cells against oxidative stress mediated apoptosis. In
this study, we aimed to investigate the role of PRDX2 in modulating β-cell functions. We detected the expression of
PRDX2 both at the transcript and protein levels in the clonal β-cells INS-1 and MIN6 as well as rodent islets.
Western blot showed that treatment of MIN6 β-cell line with proinflammatory cytokines, palmitic acid or
streptozotocin dose- or time-dependently increased apoptosis, which was associated with reduced endogenous
expression levels of PRDX2. To examine the role for PRDX2 in the apoptotic stimuli-induced β-cell apoptosis, we
used plasmid overexpression and siRNA knockdown strategies to investigate whether the elevation or knockdown
of PRDX2 affects stimuli-induced apoptosis in the β-cells. Remarkably, overexpression of PRDX2 in MIN6 cells
significantly attenuated the oxidative stresses mediated apoptosis, as evaluated by cleaved caspase 3 expression,
nuclear condensation and fragmentation, as well as FACS analysis. Conversely, attenuation of PRDX2 protein
expression using siRNA knockdown exaggerated the cell death induced by proinflammatory cytokines and palmitic
acid in the MIN6 cells. These results suggest that PRDX2 may play a protective role in pancreatic β-cells under
oxidative stress.
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Introduction
Excessive loss of pancreatic β-cell mass, mainly due to
apoptosis, is a major cause in the development of dia-
betic hyperglycemia in both type 1 and type 2 diabetes
mellitus [1]. β-cell apoptosis is initiated by a variety of
stimuli such as inflammatory cytokines, chronic hyper-
glycemia and hyperlipidemia [2,3] and downstream
effects such as endoplasmic reticulum stress [4] and
mitochondrial dysfunction [5]. Oxidative stress plays a
permissive role in the process of apoptosis leading to cell
destruction in many types of cell lineages [6,7].
Particularly the β-cells are more susceptible to oxidative
stress due to the fact that they express major antioxi-
dants such as superoxide dismutase, catalase and gluta-
thione peroxidase at low levels [1,8,9]. In the pancreatic
islets, superoxide dismutase expression is 30-40% com-
pared with that of the liver, glutathione peroxidase ex-
pression is 15%, and catalase expression cannot be
detected [10].
At the cellular level, oxidative stress-mediated β-cell
apoptosis can result from an imbalance between reactive
oxygen species (ROS) generation and its clearance by
antioxidants [9]. It has been demonstrated that proin-
flammatory cytokines induced β-cell apoptosis is
mediated through elevation of ROS in the mitochondria
via altered electron transport chain action [11], and
increased nitric oxide (NO) production via activation of
* Correspondence: qinghua.wang@utoronto.ca
1Division of Endocrinology and Metabolism, the Keenan Research Centre in
the Li Ka Shing Knowledge Institute, St. Michael's Hospital, 209 Victoria
Street, Room 414, Toronto, ON, Canada M5B 1T8
2Department of Physiology, University of Toronto, Toronto, ON, Canada
© Zhao and Wang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Zhao and Wang Cell & Bioscience 2012, 2:22
Cell & Biosciencehttp://www.cellandbioscience.com/content/2/1/22
inducible nitric oxide synthase (iNOS) [12]. The process
is known to be involved with activation of the nuclear
factor-κB (NF-κB) and the c-Jun N-terminal kinase
(JNK/SAPK) or the FAS-FAS ligand pathways [13]. In-
duction of ROS is found to be multilateral. Long chain
saturated non-esterized fatty acids (NEFA) such as pal-
mitic acid (PA) induces ROS production in the mito-
chondria through the electron transport chain [11,14].
The long chain saturated NEFAs could also directly
interact with respiratory chain proteins and increase the
oxygen radicals [15]. Streptozotocin (STZ) is a toxic
agent that causes β-cell death via DNA alkylation caus-
ing strand breaks and induction of apoptosis [16], and
local injection of STZ can produce oxidative stress in
situ causing tissue or organ dysfunction [17]. Previous
studies suggested that STZ can increase production of
oxygen radicals [18], and induction H2O2 and DNA frag-
mentation [19] in the pancreatic β-cells [16,20].
Peroxiredoxins (PRDX) are a family of antioxidant
enzymes which is capable of metabolizing hydrogen
peroxide [21]. PRDXs are thioredoxin-specific antioxi-
dants first identified in yeast and are found in archea,
prokaryotes as well as eukaryotes [22]. To date, six
members of PRDXs have been found to be expressed
in mammalian cells, as well as in the pancreatic β-
cells [23].
Previous studies have suggested that PRDX2 can regu-
late many cellular functions such as cell proliferation
and differentiation [24,25]. Through the clearance of
H2O2, PRDX2 also play critical role in the modulation of
cell survival [26]. A recent study demonstrated that at-
tenuation of PRDX2 inhibited proliferation and induced
apoptosis in granulosa cells. This was achieved through
the modulation of the NF-κB/iNOS pathway [27]. In pri-
mary cortical neurons, overexpression of PRDX2 pro-
tected against apoptosis through the suppression of the
apoptotic ASK-1 signalling pathway [28,29]. PRDX2 is
found to be relatively highly expressed in the pancreatic
islet, i.e. with up to 3 fold higher compared with the liver
[30]. However, the biological functions of PRDX2 in the
pancreatic β-cells are not known. In this study, we inves-
tigated PRDX2 expression and its role in modulating
β-cell survival and death in the mouse β-cell line MIN6.
Results
Expression of PRDX2 in pancreatic β-cells
It has been previously reported that PRDX2 is
expressed in variety of cells and tissues [31]. To de-
termine whether PRDX2 is expressed in pancreatic β-
cells, we performed RT-PCR and Western blot ana-
lysis. As shown, both PRDX2 transcripts and proteins
are detected in clonal insulin secreting cell lines, iso-
lated islets or pancreatic tissues (Figure 1A, 1B).
Oxidative stress induced apoptosis and decreased PRDX2
expression in β-cells
To examine the PRDX2 expression during the process of
oxidative stress-mediated apoptosis in the β-cells, MIN6
cells were treated with or without the oxidative stress
agents PA, cytokines or STZ at indicated concentrations
and for the indicated times. Cell lysates were subjected
to Western blot analysis using relevant antibodies. As
shown, incubation of MIN6 cells with tested oxidative
stress inducers resulted in significant apoptosis as deter-
mined by increased cleaved form of caspase-3 levels,
which was associated with decreased levels of PRDX2
expression (Figure 2A-C). Densitometry analysis of the
Western blots showed that the reduction of PRDX2
levels in the β-cells treated with various oxidative stress
agents were statistically significant (Figure 2A’-2 C’,
*p< 0.05, n = 3). These results indicate that endogenous
PRDX2 expression level is reduced upon oxidative stress
in the pancreatic β-cells.
Elevation of PRDX2 expression protects against oxidative
stress-induced apoptosis in the β-cells
To determine the role of PRDX2 in the process of oxida-
tive stress-induced β-cell apoptosis, we investigated
whether overexpression of PRDX2 would protect against
the apoptosis induced by oxidative stress stimulating
agents. Western blotting showed that elevation of
PRDX2 by transfection displayed a significant reduction
in apoptosis induced by either PA, or the cytokines or
STZ in the transfected MIN6 cells, as evaluated by the
levels of cleaved caspase-3 (Figure 3A, *p< 0.05, n = 3).
Apoptotic assays were conducted to examine the
apoptosis at the cellular level using DAPI nuclear stain-
ing. We found that the three oxidative stress agents pro-
duced profound apoptosis as determined by condensed
or fragmented nuclei in the mock transfected MIN6
cells, which was significantly reduced in the cells overex-
pressing PRDX2 (Figure 3B, *p< 0.05, n = 3). Consist-
ently, FACS using propidium iodide (Figure 3C) and
Annexin V FITC (Figure 3D) also demonstrated that the
oxidative stress induced β-cell apoptosis was remarkably
reduced in the cells overexpressing PRDX2 (*p< 0.05,
n = 3-4).
These results suggest that elevation of PRDX2 protein
expression can attenuate the apoptosis induced by PA,
or the cytokines or STZ in MIN6 cell line, which is sug-
gestive of the protective effects of PRDX2 in the β-cells.
PRDX2 knockdown exaggerated oxidative stress-induced
apoptosis in the β-cells
We further conducted knockdown studies using siRNA
method to verify the protective role of PRDX2 in the
β-cells. Transfection of MIN6 cells with PRDX2 siRNA
resulted in reduction of >80% PRDX2 in the MIN6 cells
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(Figure 4A, 4C). Western blot analysis showed signifi-
cantly exaggerated apoptosis induced by cytokines or
palmitic acid in the MIN6 cells transfected with siRNA
targeting PRDX2 but not the cells transfected with
scrambled siRNA (Figure 4B, 4D, *p< 0.05, n = 3). These
results suggested that attenuation of PRDX2 by siRNA
knockdown removes the protective effects of PRDX2
and increases apoptosis in the β-cells.
Discussion
Excessive apoptosis of the pancreatic β-cell causing loss
of β-cell mass is a major contributor to the initiation
and progression of diabetes [12,32,33]. β-cell apoptosis
can be induced by multiple stimuli including proinflam-
matory cytokines and long chain NEFAs in both type 1
and type 2 diabetes [9,34]. In rodent models of β-cell in-
jury, drugs like STZ can induce various ROS, and act
partially through oxidative stress to induce β-cell apop-
tosis that leads to the loss of β-cell mass [16,19]. Previ-
ous pre-clinical and clinical studies demonstrated that
the elevation of ROS was associated with decreased anti-
oxidant capacity in the islet β-cells in type 1 and type 2
diabetic subjects [35,36]. Islet β-cells expresses low levels
of major antioxidants therefore they are particularly
vulnerable to the detrimental effects of ROS mediated
cellular injury compared to other cell types [1,10,37]
Detection of PRDX2, both at transcript and protein
levels in the mouse pancreas, isolated mouse islets and
the clonal MIN6 cells is consistent with previous find-
ings that demonstrated the presence of PRDX2 in the
INS-1 cells and rodent islets [37]. However the bio-
logical function of PRDX2 in the β-cells was not investi-
gated. We aimed to examine whether PRDX2 has
protective effects against β-cell apoptosis that occurs
under oxidative stress conditions. In MIN6 cells, we
found that the apoptosis induced by proinflammatory
cytokines, palmitic acid, or STZ was associated with sig-
nificantly decreased endogenous PRDX2 expression. To
further study the potential role for PRDX2 in the β-cells
during oxidative stress mediated apoptosis, we overex-
pressed PRDX2 in MIN6 cells. We found that the eleva-
tion of PRDX2 expression through transfection protected
against oxidative stress mediated apoptosis. Furthermore,
reduction of PRDX2 expression through siRNA knock-
down strategy exaggerated the oxidative stress stimuli-
induced apoptosis. These findings suggest that PRDX2
may act as an important survival factor in pancreatic
β-cells.
In the β-cells, proinflammatory cytokine [38] or palmi-
tatic acid [39] induced β-cell apoptosis is partially
mediated through the activation of NF-κB pathway. In a
recent study, it has been reported that PRDX2 can pre-
vent oxidative stress induced apoptosis through modu-
lating NF-κB activity in granulosa cells [27]. It has been
shown that in embryonic fibroblast derived from mice
lacking PRDX2 exhibited increased NF-κB activities [40].
These findings suggest that PRDX2 may prevent apop-
tosis through inhibiting NF-κB. While the precise mech-
anism requires further investigation, it is likely that
PRDX2 use the similar mechanism to regulate survival
or apoptosis in the β-cells. This notion is supported by a
recent study which demonstrated that PRDX3, a peroxir-
edoxin member primarily localized in mitochondria, is
able to protect β-cell from stress due to accumulation of
hydrogen peroxide or the induction of iNOS by STZ or
inflammatory cytokines [41]. iNOS induction that acti-
vates apoptotic pathways through the activation NF-κB
has been well documented [42,43].
Our observations are consistent with previously find-
ings by others that gene expression of PRDXs is adjust-
able by oxidative stress agents. Of note, however, high
glucose induced cellular stress has no obvious effects on
other antioxidants in rat pancreatic islets or in clonal
β-cell line [44]. β-cell apoptosis induced by long chain
saturated NEFA, such as palmitic acid, is mediated
through oxidative endoplasmic reticulum (ER) stress
[45-47]. Previous studies showed that long chain NEFA
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Figure 1 PRDX2 is detected in the pancreatic β-cell lines and
islet. RT-PCR performed on RNA extracted from INS-1, MIN6, and
mouse Islet (A). Western blot performed on protein extracted from
MIN6, isolated mouse islets, and,mouse pancreas (B).
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activation of the NF-κB pathway [48] and iNOS activa-
tion [49]. In accord with this, a recent study demon-
strated that palmitate induced apoptosis in the β-cells
was attenuated by anti-diabetic agent pioglitazone, par-
tially through the suppression of NF-κB [50]. It is pre-
sumably that the anti-apoptotic effects of PRDX2,
particularly in preventing palmitic acid induced apop-
tosis in the β-cells is partially through suppression of
NF-κB. Further investigation is warranted to dissect the
precise signalling events conveying PRDX2 action to sur-
vival effectors.
Conclusions
β-cells are particularly susceptible to oxidative stress due
to low expression level of endogenous antioxidants in
these cells. We have identified that PRDX2 is highly
expressed in the β-cells. We fund that challenge INS-1
cells with cytotoxic cytokines, palmitic acid or streptozo-
tocin resulted in remarkable apoptosis associated with
reduced PRDX2 expression. Overexpression or knock-
down studies by plasmid or siRNA transfection in the
clonal β-cells in the presence of various oxidative stimuli
suggested that PRDX2 may play a protective role in
modulating pancreatic β-cell function. These findings
may provide a better understanding on the regulatory
nature of β-cell survival and apoptosis, facilitating our
efforts to identify valid targets to prevent β-cell death in
the development of diabetes.
Methods
Pancreatic islets and cell line
Mouse insulinoma cell line MIN6, passage 50–70 (from
Dr. Maria Rozakis Adcock, University of Toronto)
were maintained in RPMI 1640 medium (Invitrogen,
Burlington, ON, Canada) containing FBS (10% v/v), 100
units/ml penicillin G sodium, 100 μg/ml streptomycin
sulphate, 55 mg/500 ml sodium pyruvate, 1.14 g/500 ml
HEPES, and 1.7 μL/500 ml β-mercaptoethanol at 37 °C
in an atmosphere of humidified air (95%) and CO2 (5%).
In studies involving serum-starvation, serum was
replaced by 0.1% BSA in serum free RPMI 1640 (SFM).




































































































Figure 2 PRDX2 expression in β-cells is decreased during oxidative stress induced apoptosis. Western blot performed on proteins
extracted from MIN6 cells treated with palmitic acid for indicated concentrations (A), or cytokine cocktail for indicated duration (B), or STZ for
indicated concentrations (C). Quantitative analysis of relative PRDX2 expression and relative cleaved caspase 3 expression in MIN6 cells with SEM
(A’-C’). n = 3 *p< 0.05.
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Figure 3 Elevation of PRDX2 expression protects against oxidative stress induced apoptosis in the β-cells. Western blot of MIN6 cells
transfected with PRDX2 or empty vector (EV) and treated with indicated agents (A). Quantitative analysis of cleaved caspase 3 expression with
SEM, n = 4 *p< 0.05. Immunocytochemistry of MIN6 cells with transfected with PRDX2 (red) or EV (green) and treated with indicated agents.
Nuclei of cells were stained with DAPI (blue) (B). Quantitative analysis of abnormal nuclear morphology used as an indicator of apoptosis with
SEM. n = 3 *p< 0.05. Fluorescence assisted cell sorting (FACS) of MIN6 cells transfected with PRDX2 or EV and treated with indicated agents. Cells
were than treated with propidium iodide (PI) only or Annexin V FITC and PI and subjected to FACS. Absorbance in the FL-1 and FL-2 channel was
recorded for a minimum of 10,000 events per sample to indicate Annexin V and PI positive cells respectively. (C) Quantitative analysis of FL-2
absorbance used as an indicator of cell death with SEM. n = 4, *p< 0.05, **p< 0.01. (D) Quantitative analysis of both FL-1 and FL-2 absorbance
used as an indicator of apoptosis with SEM. n = 3, *p< 0.05.
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[51,52]. Rat islets were isolated from male Sprague–
Dawley rats (weight 150–200 g) (Charles River Canada,
Montreal, QC, Canada) as described [53,54]
Constructs used in this study
pCMVsport6-PRDX2 vector was purchased from Open
Biosystems (Huntsville, AL, USA). siGENOME smart-
pool siRNA was purchased from Dharmacon RNAi tech-
nologies (Chicago, IL, USA). Scrambled siRNA was
purchased from Ambion (Austin, TX, USA)
Oxidative stress agents and treatment
Palmitic acid was dissolved in serum free RPMI 1640
medium containing 1% fatty acid-free BSA (Sigma
Aldrich, Oakville, ON, Canada) through an incubation
of the mixture (225 rpm) at 37 °C for 3 hours allowing
for binding of PA with BSA. A cytokine cocktail mixture
(IL-1β, 10 ng/ml; TNF-α, 50 ng/ml, and IFN-γ, 50 ng/
ml, R&D Systems, Minneapolis, MN, USA) was prepared
in SFM. Streptozotocin (STZ) (Sigma Aldrich) dissolved
in the SFM was freshly prepared prior to treatment.
MIN6 cells seeded at 80% confluency in 12 well plates
the night before were serum starved for 1 hour then
treated with PA or the cytokines for indicated times, or
STZ for 4 h. Cells were either fixed or lysed for subse-
quent experimentation.
Overexpression and PRDX2 knockdown studies
Overexpression of PRDX2 in MIN6 cells was achieved
through transfection of the plasmid encoding PRDX2
(pCMVsport6-PRDX2, 1.6 μg per well of 12 well plate)
or mock transfection as control. Knockdown of PRDX2
in MIN6 cells was accomplished through transfection of
small interfering RNA (siRNA) targeting mouse PRDX2
(siGENOME SMARTpool, 40pmol per well of 12 well
plate) or scrambled siRNA as control. The day before
transfection the MIN6 cells were seeded at 5 × 105 per
well in a 12-well plate. The cells were transfected at 80%
confluency using lipofectamine 2000 according to manu-
facturer’s protocols. The transfected cells were allowed
to grow in complete medium for 24 hours post transfec-
tion before treatment with stress agents.
RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) re-
agent according to the manufacturer's instructions. RT-
PCR was performed using AffinityScript one-step
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Figure 4 Knockdown of PRDX2 expression exaggerates oxidative stress induced apoptosis in the β-cells. Western blot performed on cell
lysate of MIN6 cells with PRDX2 knockdown via siRNA transfection or scrambled control followed with treatment of 0.4 mM palmitic acid or
proinflammatory cytokine cocktail for 24 hrs (A, C). Quantitative analysis of cleaved caspase 3 expression with SEM, (B, D) n = 3 *p< 0.05.
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primers used were: PRDX2, fwd: 5’ ATCCCTCTGCT
TGCTGATGT 3’, and rev: 5’ TTGACTGTGATCTGGC
GAAG 3’; GAPDH: fwd: 5’ TGCCACTCAGAAG
ACTGTGG 3’, and rev: 5’ TTCAGCTCTGGGATG
ACCTT 3’. The DNA was first denatured at 95 °C then
annealed at 60 °C and extended at 72 °C. This was
repeated for 30 cycles before a final extension at 72 °C
for 10 minutes. The PCR product was ran on a 2% agar-
ose gel and visualized by ethidium bromide.
Western blot analysis
Cells and tissues were lysed in RIPA lysis buffer containing
the protease inhibitors phenylmethylsulphonylfluoride
(PMSF) (1 mol/l) and EDTA (1 mol/l), Na3VO4 (1 mol/l),
and NaF (1 mol/l). Protein of 25 μg was resolved by SDS-
PAGE, transferred to nitrocellulose membranes and
probed by anti-PRDX2 (1:1000, ABCAM, Cambridge,
MA, USA), GAPDH (1:20,000, ABCAM) or cleaved cas-
pase-3 (1:1000, Cell Signalling Technology Inc., Danvers,
MA, USA) visualized by enhanced chemiluminescence
(GE Healthcare Bio-Sciences Corp., Piscataway, NJ, USA)
as described previously [55]. The films were then scanned
and the intensity of the bands was quantified using ImageJ
(Research Services Branch, National Institute of Mental
Health, Bethesda, Maryland, USA) [55].
Immunocytochemistry
MIN6 cells grown on poly-L-lysine (Sigma) coated cover
slips in 12 well plates were transfected with PRDX2, or
GFP as control, using lipofectamine 2000 according to
manufacturer’s protocol. 24 hours post transfection, the
cells were serum starved (1 h) and treated with PA, the
cytokine cocktail or STZ as indicated. Cells were fixed
with 4% paraformaldehyde and blocked with 3% BSA in
PBS containing 0.1% Triton X-100 at room temperature
for 1 hour. The cells were then incubated with mouse
monoclonal PRDX2 antibody (ABCAM, 1:100) and
Alexa 555-conjugated anti-mouse IgG (Jackson Labs,
1:500), and visualized with Nikon Fluorescence micro-
scope (Eclipse TE 200). 300–450 transfected cells identi-
fied by GFP were counted per sample.
Detection of apoptosis
Apoptosis of MIN6 cells was evaluated by DAPI-nu-
clear staining based on typical chromatin condensa-
tion and fragmentation. The number of transfected
apoptotic cells was counted and compared to the
total number of transfected cells, a minimum of 300
cells were counted for each group.
Fluorescence-activated cell sorting (FACS) was used to
quantify propidium iodide (PI) and Annexin V FITC
stained cells transfected with or without PRDX2 that were
treated with palmitic acid, cytokines as indicated. FACS-
Calibur flow cytometer (Becton-Dickinson Biosciences,
Mississauga, ON, Canada) was used and the results were
analysed using FCS Express version 3 (De Novo Software,
Los Angeles, CA, USA). Fluorescence in the FL1 channel
(log green fluorescence, 485/535 nm) for Annexin V FITC
and FL2 channel (log red fluorescence, 650 nm) for PI
were acquired and recorded, using logarithmic scales, for
a minimum of 10,000 events per sample.
Statistical analysis
All data were presented as mean±SEM. Statistical ana-
lysis was performed using unpaired two-tailed Student’s
T-test or ANOVA with Bonferroni’s multiple compari-
sons post hoc test where appropriate. A p-value of less
than 0.05 was considered significant.
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